Citations

1. Gimbel H, et al. (2005). Lower urinary tract symptoms after total and subtotal hysterectomy: Results of a randomized controlled trial. International Urogynecology Journal, 16: 257–262.

2. Thakar RT, et al. (2002). Outcomes after total versus subtotal abdominal hysterectomy. New England Journal of Medicine, 347(17): 1318–1325.

3. Khastgir G, Studd J (2000). Patients' outlook, experience, and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent continuation of hormone replacement therapy. American Journal of Obstetrics and Gynecology, 183(6): 1427–1433.

4. Kuppermann M, et al. (2004). Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: The medicine or surgery (Ms) randomized trial. JAMA, 291(12): 1447–1455.

5. Gimbel H, et al. (2003). Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow-up results. International Journal of Obstetrics and Gynecology, 110: 1088–1098.

6. Benassi L, et al. (2002). Abdominal or vaginal hysterectomy for enlarged uteri: A randomized clinical trial. American Journal of Obstetrics and Gynecology, 187: 1561–1565.

7. Campbell ES, et al. (2003). Types of hysterectomy: Comparison of characteristics, hospital costs, utilization and outcomes. Journal of Reproductive Medicine, 48: 943–949.

8. Garry R, et al. (2004). The eVALuate study: Two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ, 328(7432): 129.

9. Hoffman CP, et al. (2005). Laparoscopic hysterectomy: The Kaiser Permanente San Diego experience. Journal of Minimally Invasive Gynecology, 12(1): 16–24.

10. Ghezzi F, et al. (2006). Laparoscopic-assisted vaginal hysterectomy versus total laparoscopic hysterectomy for the management of endometrial cancer: A randomized clinical trial. Journal of Minimally Invasive Gynecology, 13(2): 114–120.

11. Abramowicz M (2004). Antimicrobial prophylaxis for surgery. Treatment Guidelines from the Medical Letter, 2(20): 27–32.

12. Brown JS, et al. (2000). Hysterectomy and urinary incontinence: A systematic review. Lancet, 356(9229): 535–538.

13. Kjerulff KH, et al. (2000). Effectiveness of hysterectomy. Obstetrics and Gynecology, 95(3): 319–326.

14. Rhodes JC, et al. (1999). Hysterectomy and sexual functioning. JAMA, 282(20): 1934–1941.

15. Farquhar CM, Steiner CA (2002). Hysterectomy rates in the United States 1900–1997. Obstetrics and Gynecology, 99(2): 229–234.

16. Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA, 291(14): 1701–1712.

17. North American Menopause Society (2004). Abridged recommendations for estrogen and progestogen use in peri- and postmenopausal women: October 2004 position statement of the North American Menopause Society. Menopause Management, 13(6): 12–19. Also available online: http://www.menopausemgmt.com/issues/13-06/issue.html.

18. Rossouw JE, et al. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA, 297(13): 1465–1477.

19. Beral V, et al. (2007). Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet, 369(9574): 1703–1710.

20. American College of Obstetricians and Gynecologists Women's Health Care Physicians (2004). Breast cancer. Obstetrics and Gynecology, 104(4, Suppl): 11S–16S.

21. Million Women Study Collaborators (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362(9382): 419–427.

22. American College of Obstetricians and Gynecologists Women's Health Care Physicians (2004). Stroke. Obstetrics and Gynecology, 104(4, Suppl): 97S–105S.